期刊
BIOMARKERS IN MEDICINE
卷 9, 期 10, 页码 1025-1040出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm.15.69
关键词
biomarker; HbA(1C); miRNA; pancreatic beta-cell; Type 2 diabetes mellitus
资金
- Ramalingaswami fellowship (Department of Biotechnology - DBT, Government of India) [BT/RLF/Re-entry/11/2012]
- Savitribai Phule Pune University Research and Development
- Indian Institute of Science Education and Research, Pune
- DBT, India
Type 2 diabetes mellitus (T2DM) has reached epidemic proportions and is associated with peripheral insulin resistance. The currently used therapies aim to delay progression of T2DM. Their efficacy could drastically be improved if implemented at earlier stages. Classical diagnostic markers (blood glucose and HbA(1C)) are generally detected once metabolic imbalance has already set in. Therefore, development of biomarkers for early diagnosis would help identify individuals at risk for developing T2DM. Along with genetic predisposition, epigenetics also plays a major role in T2DM development. In this review, we discuss the potential role of early diagnostic markers such as circulating miRNAs, studies done so far and challenges to be considered while taking into account the novel role of miRNAs as prognostic biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据